Immunologic therapy for relapsing-remitting multiple sclerosis Heather J. MacLeanMark S. Freedman OriginalPaper Pages: 277 - 285
Infection and the etiology and pathogenesis of multiple sclerosis Israel SteinerPuiu NisipianuItzhak Wirguin OriginalPaper Pages: 271 - 276
T cells, cytokines, and autoantigens in multiple sclerosis Bruno GranAbdolmohamad Rostami OriginalPaper Pages: 263 - 270
Immunopathogenesis of the multiple sclerosis lesion Silva Markovic-PleseHenry F. McFarland OriginalPaper Pages: 257 - 262
Spectrum and classification of inflammatory demyelinating diseases of the central nervous system Bernadette KalmanFred D. Lublin OriginalPaper Pages: 249 - 256
Treatment of patients with secondary progressive multiple sclerosis with interferon β-1b Robert P. Lisak Clinical Trials Report Pages: 246 - 248
Immunologic approaches to therapy for brain tumors David B. PaulCarol A. Kruse OriginalPaper Pages: 238 - 244
Advances in stereotactic radiosurgery for brain neoplasms Michael D. Weil OriginalPaper Pages: 233 - 237
Migration and invasion in brain neoplasms Anna J. BolteusMichael E. BerensGeoffrey J. Pilkington OriginalPaper Pages: 225 - 232
Drug delivery to tumors of the central nervous system Maciej S. LesniakRobert LangerHenry Brem OriginalPaper Pages: 210 - 216
Diagnosis and treatment of childhood mitochondrial diseases Andrea L. Gropman OriginalPaper Pages: 185 - 194
Perinatal asphyxia: Timing and mechanisms of injury in neonatal encephalopathy Mark Scher OriginalPaper Pages: 175 - 184
Pharmacologic and genetic therapy for childhood muscular dystrophies Diana M. EscolarCheryl G. Scacheri OriginalPaper Pages: 168 - 174
Advances in biology and treatment of childhood brain tumors Alyssa T. Reddy OriginalPaper Pages: 137 - 143
Acute treatment of migraine and the role of triptans Frederick G. Freitag OriginalPaper Pages: 125 - 132
Stratified care versus step care strategies for migraine Stephen D. Silberstein Clinical Trials Report Pages: 107 - 108
Facts and an open mind should guide clinical practice Alan CarverKathleen Foley Invited Commentary Pages: 97 - 98
Progress in gene therapy for Duchenne muscular dystrophy Paula R. ClemensF Jason Duncan OriginalPaper Pages: 89 - 96
A molecular basis for hereditary motor and sensory neuropathy disorders Michael E. ShyJanne BalsamoJohn Kamholz OriginalPaper Pages: 77 - 88
Progress in the pathogenesis of amyotrophic lateral sclerosis Christopher E. ShawAmmar Al-ChalabiNigel Leigh OriginalPaper Pages: 69 - 76
Stroke in young adults and children Birgitte H. BendixenJerahme PosnerRichard Lango OriginalPaper Pages: 54 - 66
Cerebrovascular angioplasty and stenting for the Prevention of stroke John C. ChaloupkaJohn B. WeigeleWalter S. Lesley OriginalPaper Pages: 39 - 53
Choices in medical management for prevention of acute ischemic stroke James D. FleckJosé Biller OriginalPaper Pages: 33 - 38
The role of neuroimaging in selecting treatments for patients with acute stroke David GreerJamary Oliveira-FilhoWalter J. Koroshetz OriginalPaper Pages: 26 - 32
New insights on thrombolytic treatment of acute ischemic stroke James F. MeschiaThomas G. Brott OriginalPaper Pages: 19 - 25
Current status of neuroprotective agents in the treatment of acute ischemic stroke Helmi L. LutsepWayne M. Clark OriginalPaper Pages: 13 - 18
Antiplatelet aggregating versus anticoagulant agents in preventing early recurrent stroke among patients with atrial fibrillation Harold P. Adams Jr. Clinical Trials Report Pages: 11 - 12
